Background: Circulating tumor DNA (ctDNA) has emerged as a biomarker to monitor disease status in cancer patients. Limited data exists on the sensitivity of ctDNA for detection of satellite/in-transit ...

Treatment for early-stage melanoma often leads to a cure, allowing most patients to lead normal, productive lives with good quality of life. Estimates vary, but melanoma returns, or recurs, in ...